Videos From ACC.18
Watch video coverage of the hottest ACC.18 trials.
This page features scientific coverage from ACC.18 – including summary slides of the hottest late-breaking clinical trials, video interviews with experts, trial summaries, journal scans and more. This post-meeting content is meant to reinforce the teaching points and education presented during ACC.18 from three learning pathways: Heart Failure and Cardiomyopathies, Interventional Cardiology and Prevention. Click on each pathway name to see the content. Stay tuned as additional content will be added in the coming months.
Drs. Kim Eagle, Tina Shah and Salim Virani review canagliflozin for heart failure prevention in type 2 Diabetes (CANVAS); and canakinumab among patients with chronic kidney disease (CANTOS).
iScience Video: Top Three Presentations in Nutrition/Lifestyle Intervention Most Likely to Impact Practice or Research Presenter: Kim Williams Session: 1403-10 |
Summary Slide: CARES: CV Safety of Febuxostat and Allopurinol in Patients With Gout and CV Morbidities |
Clinical Trial: CARES: CV Safety of Febuxostat and Allopurinol in Patients With Gout and CV Morbidities |
iScience Video: Top Three Presentations in Hypertension Most Likely to Impact or Change Clinical Practice or Future Research Agendas Presenter: Eugene Yang Session: 1403 |
Summary Slide: BP Reduction in Black Barbershops |
Clinical Trial: BP Reduction in Black Barbershops |
iScience Video: Top Three Presentations in Dyslipidemia Most Likely to Impact or Change Clinical Practice or Future Research Agendas Presenter: Michael Shapiro Session: 1403-06 |
Clinical Trial: ACCELERATE Clinical Trial Summary |
Drs. Peter Block, Bina Ahmed and Deepak Bhatt review the cost effectiveness of instantaneous wave-free ratio vs. FFR in coronary revascularization decision-making (DEFINE-FLAIR); CYP2C19 genotyping implementation after PCI (ADAPT); and five-Year outcomes from the all-comers Nordic Aortic Valve Intervention in patients with severe AV stenosis (NOTION).
Drs. Kim Eagle, Monica Colvin and Ragavendra Baliga review MagLev Technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3); and carvedilol for prevention of chemotherapy-Induced Cardiotoxicity (CECCY).
View All ACC.18 News Coverage >>>